Founded in 1998 and headquartered in Taizhou (Zhejiang, China), Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (Jiuzhou Pharma) is a leading contract development and manufacturing organization (CDMO) specializing in small-molecule and peptide APIs. Building on its heritage in generic API manufacturing, Jiuzhou has evolved into a global CDMO supporting pharmaceutical and biotechnology companies throughout the drug development lifecycle, from preclinical CMC development and clinical supply to commercial manufacturing.
With a strong focus on innovation and sustainable pharmaceutical manufacturing, Jiuzhou develops and applies advanced technologies to improve process efficiency, reduce costs and minimize environmental impact. Our integrated development and manufacturing capabilities help partners navigate technical challenges, optimize processes and accelerate the development of new medicines.
Guided by our mission, “Serve Life, Guard Health,” we are committed to supporting our partners in bringing innovative medicines to patients worldwide.